Literature DB >> 23970540

Toxicological findings of synthetic cannabinoids in recreational users.

Robert Kronstrand1, Markus Roman, Mikael Andersson, Arne Eklund.   

Abstract

In recent years, several synthetic cannabinoid compounds have become popular recreational drugs of abuse because of their psychoactive properties. This paper presents toxicological findings of synthetic cannabinoids in whole blood from some cases of severe intoxication including quantitative data from recreational users and a fatal intoxication. Samples were analyzed by liquid chromatography-tandem mass spectrometry in a scheduled multiple reaction mode after a basic liquid extraction. Twenty-nine synthetic cannabinoids were included in the method. In our data set of ~3000 cases, 28% were found positive for one or more synthetic cannabinoid(s). The most common finding was AM-2201. Most of the analytes had median concentrations of <0.5 ng/g in agreement with other published data. The emerging drugs MAM-2201 (n = 151) and UR-144 (n = 181) had mean (median) concentrations of 1.04 (0.37) and 1.26 (0.34), respectively. The toxicity of the synthetic cannabinoids seems to be worse than that of natural cannabis, probably owing to the higher potency and perhaps also to the presence of several different cannabinoids in the smoked incense and the difficulties of proper dosing. The acute toxic effects may under certain circumstances contribute to death.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23970540     DOI: 10.1093/jat/bkt068

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  22 in total

1.  An outbreak of exposure to a novel synthetic cannabinoid.

Authors:  Andrew A Monte; Alvin C Bronstein; Dazhe J Cao; Kennon J Heard; Jason A Hoppe; Christopher O Hoyte; Janetta L Iwanicki; Eric J Lavonas
Journal:  N Engl J Med       Date:  2014-01-23       Impact factor: 91.245

Review 2.  Baths salts, spice, and related designer drugs: the science behind the headlines.

Authors:  Michael H Baumann; Ernesto Solis; Lucas R Watterson; Julie A Marusich; William E Fantegrossi; Jenny L Wiley
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

3.  Novel psychoactive substances of interest for psychiatry.

Authors:  Fabrizio Schifano; Laura Orsolini; G Duccio Papanti; John M Corkery
Journal:  World Psychiatry       Date:  2015-02       Impact factor: 49.548

4.  Four postmortem case reports with quantitative detection of the synthetic cannabinoid, 5F-PB-22.

Authors:  George Behonick; Kevin G Shanks; Dennis J Firchau; Gagan Mathur; Charles F Lynch; Marcus Nashelsky; David J Jaskierny; Chady Meroueh
Journal:  J Anal Toxicol       Date:  2014-05-29       Impact factor: 3.367

5.  Stratification of Cannabinoid 1 Receptor (CB1R) Agonist Efficacy: Manipulation of CB1R Density through Use of Transgenic Mice Reveals Congruence between In Vivo and In Vitro Assays.

Authors:  T W Grim; A J Morales; M M Gonek; J L Wiley; B F Thomas; G W Endres; L J Sim-Selley; D E Selley; S S Negus; A H Lichtman
Journal:  J Pharmacol Exp Ther       Date:  2016-08-17       Impact factor: 4.030

6.  Synthetic cannabinoid use in a nationally representative sample of US high school seniors.

Authors:  Joseph J Palamar; Patricia Acosta
Journal:  Drug Alcohol Depend       Date:  2015-02-11       Impact factor: 4.492

7.  Quantification of [1-(5-fluoropentyl)-1H-indol-3-yl](naphthalene-1-yl)methanone (AM-2201) and 13 metabolites in human and rat plasma by liquid chromatography-tandem mass spectrometry.

Authors:  Jeremy Carlier; Karl B Scheidweiler; Ariane Wohlfarth; Bonita D Salmeron; Michael H Baumann; Marilyn A Huestis
Journal:  J Chromatogr A       Date:  2016-05-06       Impact factor: 4.759

8.  Analysis of Parent Synthetic Cannabinoids in Blood and Urinary Metabolites by Liquid Chromatography Tandem Mass Spectrometry.

Authors:  Jessica L Knittel; Justin M Holler; Jeffrey D Chmiel; Shawn P Vorce; Joseph Magluilo; Barry Levine; Gerardo Ramos; Thomas Z Bosy
Journal:  J Anal Toxicol       Date:  2016-01-19       Impact factor: 3.367

Review 9.  Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications.

Authors:  Marisol S Castaneto; David A Gorelick; Nathalie A Desrosiers; Rebecca L Hartman; Sandrine Pirard; Marilyn A Huestis
Journal:  Drug Alcohol Depend       Date:  2014-08-18       Impact factor: 4.492

10.  MAM-2201, One of the Most Potent-Naphthoyl Indole Derivative-Synthetic Cannabinoids, Exerts Toxic Effects on Human Cell-Based Models of Neurons and Astrocytes.

Authors:  T Coccini; U De Simone; D Lonati; G Scaravaggi; M Marti; C A Locatelli
Journal:  Neurotox Res       Date:  2021-05-04       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.